Hologic Ownership

HOLX Stock  USD 81.21  0.25  0.31%   
The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Please note that on December 12, 2018, Senator John Reed of US Senate acquired under $15k worth of Hologic's common stock.
 
Shares in Circulation  
First Issued
1988-12-31
Previous Quarter
237.6 M
Current Value
236.5 M
Avarage Shares Outstanding
155 M
Quarterly Volatility
107 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Hologic in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Hologic, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividends Paid is likely to rise to about 71.5 M in 2024, whereas Dividend Paid And Capex Coverage Ratio is likely to drop (8.45) in 2024. Net Income Applicable To Common Shares is likely to rise to about 550.6 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 167.9 M in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Hologic Stock Ownership Analysis

About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 21.34. The company has Price/Earnings To Growth (PEG) ratio of 1.3. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.
Besides selling stocks to institutional investors, Hologic also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Hologic's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Hologic's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Hologic Quarterly Liabilities And Stockholders Equity

8.89 Billion

Hologic Insider Trades History

Less than 1% of Hologic are currently held by insiders. Unlike Hologic's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Hologic's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Hologic's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Hologic Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Hologic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hologic backward and forwards among themselves. Hologic's institutional investor refers to the entity that pools money to purchase Hologic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Fmr Inc2024-06-30
3.4 M
Mitsubishi Ufj Asset Management Co.,ltd2024-06-30
2.6 M
Northern Trust Corp2024-06-30
2.6 M
Renaissance Technologies Corp2024-06-30
2.5 M
Manufacturers Life Insurance Co2024-06-30
2.5 M
Norges Bank2024-06-30
2.4 M
Bank Of America Corp2024-06-30
2.4 M
Black Creek Investment Management Inc2024-06-30
2.3 M
Dimensional Fund Advisors, Inc.2024-06-30
2.3 M
Vanguard Group Inc2024-06-30
26.8 M
Blackrock Inc2024-06-30
23.1 M
Note, although Hologic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hologic Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Hologic's latest congressional trading

Congressional trading in companies like Hologic, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Hologic by those in governmental positions are based on the same information available to the general public.
2018-12-12Senator John ReedAcquired Under $15KVerify

Hologic Outstanding Bonds

Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hologic Corporate Filings

8K
13th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
3rd of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
30th of July 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
30th of May 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.